1. Home
  2. AG vs SYRE Comparison

AG vs SYRE Comparison

Compare AG & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Majestic Silver Corp. (Canada)

AG

First Majestic Silver Corp. (Canada)

N/A

Current Price

$19.86

Market Cap

8.5B

ML Signal

N/A

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

N/A

Current Price

$87.73

Market Cap

8.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AG
SYRE
Founded
1979
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
8.5B
IPO Year
2004
2015

Fundamental Metrics

Financial Performance
Metric
AG
SYRE
Price
$19.86
$87.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
12
Target Price
$21.92
$85.08
AVG Volume (30 Days)
9.5M
945.1K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
0.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$24.41
N/A
Revenue Next Year
$10.68
N/A
P/E Ratio
$143.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.04
$14.51
52 Week High
$32.00
$110.18

Technical Indicators

Market Signals
Indicator
AG
SYRE
Relative Strength Index (RSI) 55.54 32.38
Support Level $20.15 $81.65
Resistance Level $21.27 $106.10
Average True Range (ATR) 0.94 4.60
MACD -0.01 -2.56
Stochastic Oscillator 45.87 9.59

Price Performance

Historical Comparison
AG
SYRE

About AG First Majestic Silver Corp. (Canada)

First Majestic Silver Corp is in the business of production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. The company owns four producing mines in Mexico, consisting of the Santa Elena Silver/Gold Mine, the San Dimas Silver/Gold Mine, the Los Gatos Silver Mine, and the La Encantada Silver Mine. It also owns the Jerritt Canyon Gold Mine in Nevada, USA. Additionally, the firm holds interests in the San Martin Silver Mine and the Del Toro Silver Mine, and several exploration-stage projects. The majority of the company's revenues are from the sale of precious metals contained in dore and concentrate form. It generates maximum revenue from the sale of silver, followed by gold, zinc, copper, and other metals.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: